FilingSEC EDGAR8-K
Valion Bio Announces Positive Preclinical Safety Results for Entolimod
· SEC accepted
StagePreclinical
Filing content
The company confirmed the safety of Entolimod in a government-funded study and plans to advance to a therapeutic efficacy study evaluating survival and recovery following radiation exposure.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…